http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-188888-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d779448e816f508915ebf0e60c0ba809
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
filingDate 1997-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71f775907e01d4945043754a7ea16c34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08c8006a1fe9af2857400b6c912175bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c848547981793eb4268a6734745bd638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1953555a61b6f43297dc253ae50d0189
publicationDate 2005-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-188888-B1
titleOfInvention The use of a photosensitive compound in the manufacture of a medicament for improving visual acuity
abstract Photodynamic therapy of conditions of the eye, especially those conditions characterized by unwanted neovasculature, such as age-related macular degeneration, results in enhanced visual acuity for treated subjects.
priorityDate 1996-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449147235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433567920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3086257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66788048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154438332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410453302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148242732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 50.